Lawsuit: Roche Pharma misrepresented flu drug’s ability to contain influenza pandemic
BALTIMORE – Drug company Hoffmann-La Roche (OTCMKTS – RHHBY) bilked U.S. federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit.
Continue reading “Tamiflu Fraud Bilked $1.5 Billion From Government, Alleges Whistleblower”
